André Cantin

Prix et distinctions

• (2007) CCFF 2007 Hall of fame award. (Distinction).
• (1999) Marsha Morton Scholarship, Canadian Cystic Fibrosis Foundation. (Honneur).
• 2000-2001 Zellers Award. (Distinction).
• Armand-Frappier Prize. (Citation).
• Commemorative medal 125th Anniversary conf Canada. (Distinction).
• Commemorative medal Queen of the Elizabeth II Golden Jubilee Medal in recognition of work with the Canadian Cystic Fibrosis Foundation, May 2002. (Honneur).
• Commemorative medal of the Queen Elizabeth II Diamond Jubilee Medal in recognition of work with the Canadian Cystic Fibrosis Foundation, November 10th, 2012. (Honneur).
• Fellowship. (Distinction).
• Medal in Medicine. Collège Royal des Médecins et Chirurgiens du Canada. (Distinction).
• Prix d'excellence en recherche du CA du CHUS. (Distinction).
• Prix de l'AMLFC des Médecins de Coeur et d'action. (Distinction).
• Researcher, month of August 2006 on website «Canadians for Health Research»/ Chercheur du mois d’août 2006 du site web «Les Canadiens pour la recherche médicale», www.chrcrm.org. (Distinction).
• Récipiendaire du prix « Spécialiste en médecine d’investigation ». Prix des médecins de cœur et d’action 2003, Association des médecins de langue française du Canada. (Honneur).

Publications

Articles de revue

• Cantin A, Hartl D, Konstan MW, Chmiel JF. (2014). Inflammation in cystic fibrosis lung disease: pathogenesis and therapy. Journal of Cystic Fibrosis. (Article soumis).
• Cloutier A, Cantin AM. (2014). Lung epithelial lining fluid glutathione in health and disease. AJRCMB, under review, 2014. (Article soumis).
• Cantin AM, Ouellet C, Bilodeau G, Cloutier D, Cloutier A, Speert D. (2014). Mucins and bicarbonate regulate NADPH oxidase activity: implications for cystic fibrosis lung disease. Submitted 2014. JCI (Article soumis).
• Morin C, Cantin A, Rousseau E, Sirois M, Sirois C, Rizcallah E, Fortin S. (2014). Pro-resolving action of MAG-DHA in lung inflammatory models related to cystic fibrosis. AJRCMB, under review 2014. (Article soumis).
• Marois I , Cloutier A , Meunier I , Weingartl HM , Cantin AM , Richter MV. (2014). Inhibition of influenza virus replication by targeting broad host cell pathways. PloS one 9 (10), e110631. (Article publié).
• Fugère A , Lalonde Séguin D , Mitchell G , Déziel E , Dekimpe V , Cantin AM , Frost E , Malouin F. (2014). Interspecific small molecule interactions between clinical isolates of Pseudomonas aeruginosa and Staphylococcus aureus from adult cystic fibrosis patients. PloS one 9 (1), e86705. (Article publié).
• Morin C , Fortin S , Cantin AM , Sirois M , Sirois C , Rizcallah E , Rousseau É. (2013). Anti-cancer effects of a new docosahexaenoic acid monoacylglyceride in lung adenocarcinoma. Recent patents on anti-cancer drug discovery 8 (3), 319-34. (Article publié).
• Morin C , Fortin S , Cantin AM , Rousseau É. (2013). MAG-EPA resolves lung inflammation in an allergic model of asthma. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 43 (9), 1071-82. (Article publié).
• Bossé D , Lemire C , Ruel J , Cantin AM , Ménard F , Valiquette L. (2013). Severe anaphylaxis caused by orally administered vancomycin to a patient with Clostridium difficile infection. Infection 41 (2),
• Mitchell G , Fugère A , Pépin Gaudreau K , Brouillette E , Frost EH , Cantin AM , Malouin F. (2013). SigB is a dominant regulator of virulence in Staphylococcus aureus small-colony variants. PloS one 8 (5), e65018. (Article publié).
• Morin C , Fortin S , Cantin AM , Sirois M , Sirois C , Riscallah E , Rousseau E. (2012). Anti-Cancer Effects of a New Docosahexaenoic Acid Monoacylglyceride in Lung Adenocarcinoma. Recent patents on anti-cancer drug discovery
• Cantin AM , Richter MV. (2012). Cigarette smoke-induced proteostasis imbalance in obstructive lung diseases. Current molecular medicine 12 (7),
• Cloutier A , Marois I , Cloutier D , Verreault C , Cantin AM , Richter MV. (2012). The prostanoid 15-deoxy-Δ12,14-prostaglandin-j2 reduces lung inflammation and protects mice against lethal influenza infection. The Journal of infectious diseases 205 (4),
• Cantin AM , Bilodeau G , Larivée P , Richter MV. (2012). Plasma biomarkers and cystic fibrosis lung disease. Clinical and investigative medicine. Médecine clinique et experimentale 35 (4),
• Mitchell G , Grondin G , Bilodeau G , Cantin AM , Malouin F. (2011). Infection of polarized airway epithelial cells by normal and small-colony variant strains of Staphylococcus aureus is increased in cells with abnormal cystic fibrosis transmembrane conductance regulator function and is influenced by NF-κB. Infection and immunity 79 (9),
• Morin C , Fortin S , Cantin AM , Rousseau E. (2011). Docosahexaenoic acid derivative prevents inflammation and hyperreactivity in lung: implication of PKC-Potentiated inhibitory protein for heterotrimeric myosin light chain phosphatase of 17 kD in asthma. American journal of respiratory cell and molecular biology 45 (2),
• Pier G , Prince A , Cantin A. (2011). Cystic fibrosis: an-ion transport issue?. Nature medicine 17 (2),
• Cantin AM. (2010). Cellular response to cigarette smoke and oxidants: adapting to survive. Proceedings of the American Thoracic Society 7 (6),
• Mitchell G , Séguin DL , Asselin AE , Déziel E , Cantin AM , Frost EH , Michaud S , Malouin F. (2010). Staphylococcus aureus sigma B-dependent emergence of small-colony variants and biofilm production following exposure to Pseudomonas aeruginosa 4-hydroxy-2-heptylquinoline-N-oxide. BMC microbiology 10
• AM Cantin. (2009). Fibrose kystique (mucoviscidose): Modalités thérapeutiques pour corriger le défaut de base. Revue des Maladies respiratoires. (Suppl 1), S65-7. (Article publié).
• Koteva K, Cantin AM, Neugebauer WA, Escher E. (2001). Synthesis and evaluation of novel b-lactam inhibitors of human leukocyte elastase. Can J Chem 79 377-87. (Article publié).
• Maiti SN, Woods DE, Cantin AM. (1998). 2-Spirocyclopropyl cephem sulfones: Human neutrophil elastase inhibitors. Drugs of the Future 23 (6), 635-41. (Article publié).
• Morin C, Fortin S, Cantin AM, E Rousseau. CPI-17 controlled cell proliferation in lung adenocarcinoma: anti-tumorigenic effect of DHA monoacylglyceride. American Journal of Physiology-Lung Cellular and Molecular Physiology (Article soumis).

Chapitres de livre

• AM Cantin. (2010). Cystic fibrosis. In: Molecular Basis of Pulmonary Disease, Insights from Rare Lung Disorders. Springer Science + Business Medicine. (2010, 339-368). Ed: Drs Francis X McCormack, Ralph J Panos, Bruce C Trapnell, Humana Press. (Article publié).
• Cantin AM, Fournier A, Leduc R. (2004). Human leukocyte elastase and cystic fibrosis. In: Proteases in Biology and Disease, volume 1. Proteases in tissue remodelling of lung and heart. (2004, 1-34). NM. Hooper and U. Lendeckel. Kluwer Academic/Plenum Publishers,. (Article publié).
• Cantin AM, Dugas M. (2002). Les fibroses pulmonaires. In: Pneumologie clinique. Collection Omnipraticien. (2002, 387-408). P Nadeau et JJ Gauthier, eds.Les Presses de l’Université de Montréal. (Article publié).
• Cantin AM, B. Paquette. (1999). Oxidants and antioxidants in lung injury: potential links with LAM. In: LAM and other diseases characterized by smooth muscle muscle proliferation. (1999, 131, 517-31). J. Moss and C Lenfant, ed., Marcel Dekker Inc. (Article publié).
• Lavoie A, Cantin AM, Escher E. (1996). Development of beta-lactam peptides for elastase inhibition in cystic fibrosis. Peptides: Chemistry, structure and biology. Chapter 117: 297-298, 1996. (1996, 297-8). (Article publié).
• Bégin R, Cantin A, Dufresne A, Sébastien P, Poncy JL, Rabin E, Duport P. (1996). In vivo dissolution, translocation and organ clearance or accumulation of uranium compounds. AECB Canada Report, pp 1-40, 1996. (1996, 1-40). (Article publié).
• Bégin R, Dubois F, Cantin A, Massé S, Dufresne A, Perrault G, Sébastien P. (1991). Les bienfaits de l’inhalation de l’aluminium chez le mouton silicotique. Colloque INSERM,Mechanisms in occupational lung diseases, 203: 305-310, 1991. (1991, 203, 305-11). (Article publié).
• Bégin R, Dubois F, Cantin A, Massé S, Dufresne A, Perrault G, Sébastien P. (1990). Aluminum inhalation reduces silicosis in a sheep model. Proceedings of the 7th International Pneumoconioses conference. DHHS (NIOSH), #90-108, part 1, pp 895-896, 1990. (1990, 90-108, 895-6). (Article publié).
• Bégin R, Dufresne A, Cantin A, Massé S, Sébastien P, Durand P, Perrault G. (1990). Carborundum pneumoconiosis. Proceedings of the 7th International Pneumoconioses conference. DHHS (NIOSH), #90-108, part 1, 1193-1194, 1990. (1990, 90-108, 1193-4). (Article publié).
• Bégin S, Massé S, Cantin A, Bisson G, Bergeron D. (1990). Imaging the pneumoconioses in 1988: a multidisciplinary approach. Proceedings of the 7th International Pneumoconioses conference. DHHS (NIOSH), #90-108, part 1, pp 1195-1197, 1990. (1990, 90-108, 1195-7). (Article publié).
• Bégin R, Ostiguy G, Cantin A, Bergeron D. (1990). Lung function in silica exposed workers. Proceedings of the 7th International Pneumoconioses conference. DHHS (NIOSH), #90-108, part 1, pp 518-519, 1990. (1990, 90-108, 518-9). (Article publié).
• Bégin R, Cantin A, Drapeau G, Lamoureux G, Boctor M, Massé S, Rola-Pleszczynski M. (1985). Pulmonary uptake of gallium-67 in asbestos-exposed humans and sheep. Year Book of Nuclear Medicine, pp 245-246, 1985. (1985, 245-6). (Article publié).
• Bégin R, Cantin A, Berthiaume Y, Bisson G, Lamoureux G, Rola-Pleszczynski M, Boctor M, Dalle D, Brault J, Massé S. (1984). Detection of early asbestosis. ILO VIth International Pneumoconiosis Conference Monograph, vol 2, pp 846-867, 1984. (1984, 2, 846-67). (Article publié).
• Bégin R, Massé S, Cantin A, Ménard HA, Bureau MA. (1983). Airway disease in a subset of nonsmoking rheumatoid patients: characterization of the disease and evidence for an autoimmune pathogenesis. Year Book of Medicine, Chapter 13: 127-128, 1983. (1983). (Article publié).

Articles de conférence

• Cantin AM, Ouellet C, Cloutier D, Bilodeau G, Cloutier A, Speert D. (2014). Mucins and bicarbonate regulate neutrophil NADPH oxidase activity. North American CF Conference, Atlanta, Georgia October 9-11, 2014. (Article accepté).
• Cantin AM, Labbé J, Martel M, Bilodeau G, Cloutier A. (2014). Pirfenidone inhibits the hypoxia-inducible factor-1 (HIF-1) pathway and prevents pulmonary hypoxia and fibrosis in vivo. ATS 2014, San Diego, California, USA, May 16-21, 2014. (Article publié).
• Cantin, AM, Martel M, Labbé J, Poulin Y. (2013). Dichloroacetate improves survival in a murine model of acute respiratory distress syndrome. ATS 2013, Philadelphia, PA, May 17-22, 2013. (Article accepté).
• Beaudoin, BG, Chiasson M, Couture E, Dumoulin E, Larivée P, Cantin A, Poulin Y. (2013). Etiologies, investigations and outcomes of patients presenting with hemoptysis in a North-American tertiary center at the beginning of the 21st century. ATS 2013. (Article accepté).
• Lafond PA, Beaudoin-Grondin B, Poulin Y, A Cantin. (2013). Pulmonary alveolar proteinosis followed by Burkitt lymphoma, both of which responded with rituximab. American Thoracic Society 2013, Philadelphia USA, May 17-22, 2013. (Article publié).
• Chmiel JF, Ziady AG, Cantin A, Erzurum SC, Hazen SL, Schluchter M, Margevicius S, Bucur C, Campbell PW, et MW Konstan. (2012). A Pilot Study Evaluating the Effect of Sulforaphane in Broccoli Sprouts on Nrf2 Activation, Measures of Oxidative Stress, and Neutrophil Migration to Mucosal Surfaces in Healthy Volunteers and Subjects with Cystic Fibrosis. North American CF Conference, Orlando, Floride, October 2012 (submitted). (Article soumis).
• Beaudoin BG, Poulin Y, Leclair MA, Cantin AM and Sirois M. (2012). Arteriovenous extracorporeal membrane carbone dioxide removal as a bridge to lung transplantation in cystic fibrosis. ATS 2012, San Francisco, CA, May 18-23, 2012. (Article publié).
• Beaudoin EL, Dumoulin E, Cantin AM, and Y Poulin. (2012). Pleurodesis in spontaneous pneumothorax: a retrospective study comparing quinacrine to talc and mechanical pleurodesis. ATS 2012, San Francisco, CA, May 18-23, 2012. (Article publié).
• Séguin DL, Mitchell G, Cantin A, Michaud S, Frost E, Malouin F. (2010). Antibiotic resistance and genetic diversity of staphylococcus aureus and small colony variants (SCV) from adult cystic fibrosis (CF) patients. 50th ICAAC. (Article publié).
• Cloutier A, Marois I, Verreault C, Cloutier D, Weingartl H, Cantin AM, Richter MV. (2010). Cloutier A, Marois I, Verreault C, Cloutier D, Weingartl H, Cantin AM, Richter MV. Targeting the PPAR-gamma pathway protects against lethal influenza infection. Canadian Pandemic Preparedness Meeting: Outcomes, Impacts and Lessons Learned/Rencontre canadienne sur la capacité d'intervention en cas de pandémie, IRSC, Montréal, Québec, November 12-13, 2010. (Article publié).
• Marois I, Cloutier A, Cloutier D, Cantin AM, Richter MV. (2010). Effet de l’altération de voies fonctionnelles de la cellule hôte sur l’infection par le virus de l’influenza. Journée Scientifique, Faculté de Médecine et Sciences de la Santé, Université de Sherbrooke, March 24, 2010. (Article publié).
• Marois I, Cloutier A, Verreault C, Cloutier D, Weingartl H, Cantin AM, Richter MV. (2010). Inhibition of Influenza Virus Infection by Targeting Broad Host Cell Mechanisms. Influenza. Translating basic insights, Washington DC, USA, December 2-4, 2010. (Article publié).
• Marois I, Cloutier A, Verreault C, Cloutier D, Weingartl H, Cantin AM, Richter MV. (2010). Inhibition of influenza virus Infection by targeting broad Host cell mechanisms. Canadian Pandemic Preparedness Meeting: Outcomes, Impacts and Lessons Learned/Rencontre canadienne sur la capacité d'intervention en cas de pandémie, IRSC, Montréal, Québec, November 12-13, 2010. (Article publié).
• Dumoulin E, Martel M, Cloutier D, Cantin AM. (2010). Nrf2 versus peroxisome proliferator-activated receptor-gamma (PPARgamma) as therapeutic targets for idiopathic pulmonary fibrosis. ATS 2010, New Orleans, Louisiana, May 14-19, 2010. (Article publié).
• Beaulieu A, Cloutier A, Aubin K, Verreault C, Leduc R, Cantin AM, Richter MV. (2010). TTSPs are differentially expressed in bronchial and alveolar epithelial cells and their inhibition blocks influenza virus replication in vitro. Journée phare, Sherbrooke, Qc, November 5, 2010. (Article publié).
• Cloutier A, Marois I, Verreault C, Cloutier D, Weingartl H, Cantin AM, Richter MV. (2010). The PPAR-gamma agonist, 15-deoxy-delta-12.14-PGJ2, protects against lethal influenza infection. Translating basic insights, Washington DC, USA, December 2-4, 2010. (Article publié).
• Marois I, Cloutier A, Cloutier D, Cantin AM, Richter MV. (2010). Étude de l’efficacité de traitements alternatifs anti-influenza ciblant des mécanismes cellulaires de l’hôte,. Journée de la Recherche 2010 de l’Université de Sherbrooke, February 10, 2010. (Article publié).
• Dumoulin E, Martel M, Cantin AM. (2009). Cigarette smoke exposure, endoplasmic reticulum stress and transforming growth factor beta. ATS 2009. San Diego, May 15-20, 2009. (Article publié).
• Seguin DL, Mitchell G, Cantin A, Michaud S, Frost E, Malouin F. (2009). Effect of antibiotic therapy on Staphylococcus aureus (SA) colonization and detection of small colony variants (SCV) in the respiratory tract of adult cystic fibrosis (CF) patients. 49th ICAAC meeting. (Article publié).
• Girard-Tremblay L, Pelloux S, Bilodeau G, Cloutier D, Martel M, Rousseau E, Cantin A. (2009). Effet de la perte de fonction du CFTR sur le mucus produit par les cellules Calu-3. 51e Réunion annuelle du Club de Recherches Cliniques du Québec (CRCQ), Lac Delage, Qc. (Article publié).
• Verreault C, Leduc R, Cantin AM, Richter MV. (2009). Identification des protéases humaines impliquées dans l’activation de l’hémagglutinine du virus de l’influenza A à l’aide d’un nouveau modèle de cellules épithéliales bronchiques. 51e Réunion annuelle du Club de Recherches Cliniques du Québec (CRCQ), Lac Delage, Qc, September 24-26, 2009. (Article publié).
• Cantin AM, Bilodeau G, Pelloux S. (2009). Plasma human leukocyte elastase and alpha-1 antiproteinase complexes reflect cystic fibrosis lung disease. NACFC 2009, Minneapolis, Minnesota, October 15-17, 2009. (Article publié).
• Massy C, Turcotte E, Cantin AM, Bouchard N. (2009). Risk of malignancy of pulmonary nodules with low 18F-FDG uptake on PET scan images. Journée scientifique du département de médecine, faculté de médecine et des sciences de la santé, Université de Sherbrooke, November 13, 2009. (Article publié).
• Massy C, Turcotte E, Cantin AM, Bouchard N. (2009). Risk of malignancy of pulmonary nodules with low 18F-FDG uptake on PET scan images. ATS 2009, session A22 Clinical Topics in lung cancer: poster discussion session (308), San Diego, May 15-20, 2009. (Article publié).
• AM Cantin, Basque J, Martel M, Leduc R. (2008). AM Cantin, Basque J, Martel M, Leduc R. Chemically modified tetracycline CMT3 decreases mature TGFbeta1 levels in A549 cell line supernatants. Am J Respir Crit Care Med, 177, A727. (Article publié).
• Maurice K, Leduc R, Cantin AM. (2008). Human airway trypsin-like protease and Calu-3 cell interactions: implications for cystic fibrosis. NACFC, Orlando, Florida, October 23-25, 2008. (Article publié).
• Basque J, Martel M, Blanchard J, Leduc R, Cantin AM. (2007). Chloroquine and doxycycline prevent TGFbeta maturation by suppressing furin activity in the alveolar cell line A549. Am J Respir Crit Care Med, 175; A730. (Article publié).
• Cantin AM, Gomes M. (2007). Effect of 1H-purine nasal instillation on bleomycin lung injury in mice. Am J Respir Crit Care Med, 175: A738, 2007. (Article publié).
• Ouellet C, Cloutier D, Cantin AM. (2007). Human respiratory mucins, cationic peptides and host defences. Am J Respir Crit Care Med, 175: A320, 2007. (Article publié).
• AM Cantin. (2007). Oxidants and antioxidants in lung disease: therapeutic implications. International Society for Aerosols in Medicine Congress (ISAM), Tours, France, June 15-20, 2007. (Article publié).

Autres contributions

Gestion d'évènements

• Co-chair/Co-président, organizing committee/comité organisateur. 18ième NACFC meeting. (Conférence).
• Principal organizor/organisateur. Broken Arrow Conferences Canadian Cystic Fibrosis Foundation (1993-present). (Atelier).
• Co-organizer and session moderator. Consensus conference: « The inflammatory process in the CF lung » of the Cystic Fibrosis Foundation. Washington, DC, February 2000. (Conférence).
• Co-organizer/co-organisateur. Course on lung defense 2000, 14th Annual American Cystic Fibrosis Conference, Baltimore, MD, November 9, 2000. (Cours).
• Président/Chairman, panel discussion. Cystic fibrosis session. November 1st 2005, CHEST congress 2005, Montreal, QC, October 29 – November 2nd, 2005. (Conférence).
• Member. Member, program planning committee, 27th NACFC meeting, 2013. (Conférence).
• Member, organizing committee/Membre du comité organisateur. North-American Cystic Fibrosis conference (1998-present).
• Président/Chairman. North American Cystic Fibrosis Conference. St-Louis, MO, October 2004. (Conférence).
• Président/Chairman. Comité organisateur/organizing committee. Provincial Cystic Fibrosis Conference, Manoir des sables, Mont-Orford, QC, May 2006.
• Membre. Research Subcommittee CCFF, 14th Broken Arrow Conference, Quebec, April 7-8, 2011. (Conférence).
• Chairman/président. Workshop for a Canadian CF Clinical Trials Network, Toronto, Ont. February 1994. (Atelier).
• Co-organisateur, co-organisor. Young investigators Forum - IRSC, Winnipeg, May 2005. (Atelier).

Présentations

• (2015). La fibrose pulmonaire idiopathique. Symposium sur les maladies interstitielles 2015. Montréal
• (2015). Conference: Can Cystic Fibrosis (CF) and alpha-1 antitrypsin deficiency (AATD) inform COPD?. Conference: Can Cystic Fibrosis (CF) and alpha-1 antitrypsin deficiency (AATD) inform COPD?. Miami
• (2014). Conférence réseau: nouveautés et mise à jour sur la fibrose pulmonaire idiopathique. Congrès québécois en santé respiratoire, November 6, 2014. Montréal
• (2014). Mucus et immunité : une harmonie complexe orchestrée par le CFTR. Mucus et immunité : une harmonie complexe orchestrée par le CFTR. 25e anniversaire du CFTR. Fibrose kystique Québec, McGill University. Montréal
• (2014). Les maladies pulmonaires interstitielles : FPI, COP, pneumonies éosinophiliques et traitements. Les maladies pulmonaires interstitielles : FPI, COP, pneumonies éosinophiliques et traitements. Congrès de l’Association des spécialistes en médecine interne du Québec (ASMIQ). Montréal
• (2014). Fibrose pulmonaire idiopathique : une mise à jour. ibrose pulmonaire idiopathique : une mise à jour. Société canadienne des thérapeutes respiratoires. Montréal
• (2014). CFTR: To cystic fibrosis… and beyond. Workshop on CFTR and lung infections. CFTR: To cystic fibrosis… and beyond. Workshop on CFTR and lung infections, Meakins-Christie. Montréal
• (2013). Présentation réseau: conférence sur la fibrose pulmonaire. Congrès québécois en santé respiratoire, Montréal, QC, November 14-15 2013. Montréal
• (2013). Plasma biomarkers to determine severity of lung function in CF. 36th Europen Cystic Fibrosis Conference 2013, Lisbon, Portugal, June 12-15, 2013. Lisbon
• (2013). Respiratory research: a canadian luxury?. Ghost River Retreat 2013, March 9-10, 2013. Ghost River
• (2013). The science-friendly clinician. Ghost River Retreat 2013, March 9-10, 2013. Ghost River
• (2012). Mise à jour de la recherche en fibrose kystique et implications thérapeutiques. Dans le cadre : Le courage de changer. Journée provinciale de fibrose kystique, Hôtel Fairmount Le Reine Élizabeth, Montréal, Qc, May 25, 2012. Montréal
• (2012). Cystic fibrosis : research and hope/La fibrose kystique : recherche et espoir. Biotech City 10th Anniversary Symposium/Symposium du 10e anniversaire de la Cité de la Biotech, Laval, Qc, May 2-3, 2012. Laval
• (2012). Guest speaker/conférencier invité. Mechanisms of abusive inflammation. 14th Broken Arrow Conference: Infection and Inflammation organized by the Canadian Cystic fibrosis Foundation, Quebec City, QC. April 2011. Québec
• (2011). Les tests de fonction respiratoire. Présentation aux médecins de l’Hôpital Youville. Sherbrooke
• (2011). Fibrose pulmonaire idiopathique : à la recherche d’un traitement. CURSUS Santé, Université de Sherbrooke, May 10, 2011. Sherbrooke
• (2011). La recherche en fibrose kystique : de nouvelles pistes de solution. CURSUS Santé, Université de Sherbrooke, May 10, 2011. Sherbrooke
• (2011). La recherche en fibrose kystique : 2011. Journée provinciale de fibrose kystique, May 2011.
• (2011). Le contrôle des infections en fibrose kystique : de nouvelles pistes de solutions. AGM, Canadian Cystic Fibrosis Foundation. Toronto
• (2010). La recherche en fibrose kystique : 2010. Journée provinciale de fibrose kystique.
• (2010). La fibrose pulmonaire idiopathique: séparer l’idiot du “pathique”. Grand rounds, Department of Medicine, Faculté de médecine et des sciences de la santé, Université de Sherbrooke. Sherbrooke
• (2010). Airway inflammation in CF: Recognizing what is clinically meaningful. 10th Killarney National Cystic Fibrosis Conference, Killarney, Ireland, February 4-5, 2010. Killarney
• (2010). Cigarette/Lung cell targets. Session entitled: Cellular response to cigarette smoke and oxidants. Transatlantic airway conference, January 20-22, 2010. Lucerne